RPAM
KURA icon

Rhenman & Partners Asset Management’s Kura Oncology KURA Stock Holding History

Rhenman & Partners Asset Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.21M Sell
271,500
-600,500
-69% -$5.16M 0.27% 79
2025
Q4 		$9.06M Buy
872,000
+382,000
+78% +$4.01M 0.85% 48
2025
Q3 		$4.34M Buy
490,000
+240,000
+96% +$1.71M 0.48% 61
2025
Q2 		$1.44M Buy
250,000
+55,000
+28% +$337K 0.18% 79
2025
Q1 		$1.29M Sell
195,000
-119,526
-38% -$931K 0.15% 78
2024
Q4 		$2.74M Buy
314,526
+148,000
+89% +$2.13M 0.28% 73
2024
Q3 		$3.25M Hold
166,526
– – 0.26% 78
2024
Q2 		$3.43M Hold
166,526
– – 0.33% 69
2024
Q1 		$3.55M Buy
+166,526
New +$3.24M 0.34% 59

Other funds holding KURA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return